Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer.
Sarah BétrianMartina Aida AngelesAntonio Gil MorenoBastien CabarrouMarion DeslandresGwenael FerronEliane MeryAnne FloquetFrederic GuyonAssumpció Pérez-BenaventeEmanuela SpagnoloAgnieszka RychlikLaurence GladieffAlicia Hernández GutiérrezAlejandra MartinezPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
In our cohort, the number of neoadjuvant chemotherapy cycles was not associated with disease-free survival or overall survival. Chemotherapy response score 3 improved oncological outcome regardless of the number of neoadjuvant chemotherapy cycles.